docetaxel anhydrous has been researched along with Melanoma, Amelanotic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arra, C; Barbieri, A; Conte, C; Leone, N; Maglio, G; Mazzaglia, A; Palma, G; Quaglia, F; Sciortino, MT; Siracusano, G; Tirino, P; Ungaro, F | 1 |
1 other study(ies) available for docetaxel anhydrous and Melanoma, Amelanotic
Article | Year |
---|---|
Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancer.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Survival; Docetaxel; Drug Carriers; Drug Stability; Female; Hemolysis; Humans; Indoles; Isoindoles; Melanoma, Amelanotic; Mice; Mice, Nude; Nanoparticles; Organometallic Compounds; Photochemotherapy; Photosensitizing Agents; Plasma; Singlet Oxygen; Skin Neoplasms; Taxoids; Tumor Burden; Zinc Compounds | 2013 |